41.63
-1.75 (-4.03%)
-1.75 (-4.03%)
Upgrade to Real-Time
Afterhours
Low
9.59
High
46.4186
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celldex Therapeutics Inc | CLDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -1.75 | -4.03% | 41.63 | 16:17:14 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 42.96 | 41.334 | 43.29 | 41.63 | 43.38 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 41.15 | 44.00 | 2.85 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,924 | 464,914 | $ 42.17 | $ 19,607,026 | - | 9.59 - 46.4186 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:09:05 | 1 | $ 42.27 | USD |
Period:
Draw Mode:
Celldex Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.93B | 46.46M | 46.23M | $ 7.42M | $ - | -2.17 | -22.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 839.00k | 16.50% |
Celldex Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLDX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 39.38 | 44.96 | 39.38 | 43.33 | 600,815 | 2.25 | 5.71% |
| 1 Month | 34.90 | 46.4186 | 28.30 | 40.44 | 1,475,797 | 6.73 | 19.28% |
| 3 Months | 30.42 | 46.4186 | 23.9501 | 35.74 | 849,930 | 11.21 | 36.85% |
| 6 Months | 19.49 | 46.4186 | 15.37 | 30.05 | 765,230 | 22.14 | 113.6% |
| 1 Year | 10.80 | 46.4186 | 9.59 | 23.33 | 713,027 | 30.83 | 285.46% |
| 3 Years | 0.496 | 46.4186 | 0.17 | 8.10 | 999,978 | 41.13 | 8,293.15% |
| 5 Years | 4.69 | 46.4186 | 0.17 | 4.95 | 1,386,122 | 36.94 | 787.63% |
Celldex Therapeutics Description
| Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. |
